About this Blog
The coronavirus (COVID-19) pandemic has not left any country spared and health systems face challenges on multiple fronts. Cardiovascular disease is the world’s largest cause of morbidity and mortality. It is emerging as a common risk factor at baseline in the individuals most likely to have poor outcomes from COVID-19 infection. There is little yet known about the potential cardiac complications which may occur following COVID-19 infection, and there are many questions to be answered, whether through epidemiology and basic science or trials and pharmacology. In this blog, “The Heart in the Time of COVID-19”, WHF Emerging Leaders combine global perspective with updates of relevant the most recent science relating to cardiovascular disease and COVID-19. We hope this knowledge will be shared widely and together we can learn how to prevent and treat this disease which is truly unprecedented in its scale.
by: Amitava Banerjee and Pablo Perel
Please click here for a table of contents.
Latest from the Blog
by:Aaysha Cader Whilst much has been written about COVID-19 and its inflammation-thrombosis-hypercoagulability cascade, this has to a large extent focused on venous thromboembolism (VTE). As more data emerges, it is evident that the intense inflammatory response associated with SARS-COV-2 infection may trigger thrombosis across multiple vascular beds, with large thrombus burden in ST-segment elevation myocardialContinue reading “Do COVID STEMIs have a higher thrombus burden? More questions & implications”
by:Abraham Samuel Babu Cardiac rehabilitation (CR) is an integral part of cardiovascular care. Yet, it is one of the most underutilised evidence based intervention across the world.1 With uptake to CR varying greatly around the world, the novel 2019 coronavirus (COVID19), has been no help to this. Nevertheless, this has brought the entire CR communityContinue reading “Cardiac rehabilitation in the time of COVID19”
by:Eduardo Chuquiure-Valenzuela In several COVID-19 cases, acute myocarditis results in focal or global myocardial inflammation, necrosis1. Clinically presents ventricular dysfunction and tachyarrhythmias2-3. Also, may influence in cardiac contractile worsening with a severe impact on Heart Failure (HF). It is postulated that Heart Failure risk is mediated by a decrease in myocardial oxygen supply caused byContinue reading “Heart failure and COVID-19: A dynamic and changing interaction”
Get new content delivered directly to your inbox.